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CRACOver the last twenty years, evidence has been provided that the plasma membrane is partitioned with microdo-
mains, laterally mobile in the bilayer, providing the necessary microenvironment to speciﬁc membrane proteins
for signalling pathways to be initiated.Wediscuss here the importance of suchmicrodomains for Toll-like receptors
(TLR) localization and function. First, lipid microdomains favour recruitment and clustering of the TLR machinery
partners, i.e. receptors and co-receptors previously identiﬁed to be required for ligand recognition and signal trans-
mission. Further, the presence of the so-called Cholesterol Recognition Amino-Acid Consensus (CRAC) sequences in
the intracellular juxtamembrane domain of several Toll-like receptors suggests a direct role of cholesterol in the ac-
tivation process. This article is part of a Special Issue entitled: Lipid-protein interactions.
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It has been shown for years that membrane protein activity is modu-
lated by the lipids that surround them. Some proteins sense directly the
membrane physico-chemical properties such as ﬂuidity, polarity, curva-
ture, hydrophobic mismatch, thickness and lateral membrane tension.
In other cases, speciﬁc interactions between deﬁned protein motifs and
given lipids have been evidenced. Since the seminal hypothesis of a
ﬂuid mosaic model membrane [1], an overwhelming body of evidence
was collected that supports the existence in the membrane of differenti-
ated domains characterized by a speciﬁc chemical composition. One ex-
ample of such microdomains is the so-called membrane rafts that were
proposed to be transient domains enriched in sphingolipids, cholesterol
and saturated lipids [2,3]. These lipids are laterally mobile in the bilayer,
leading to changes in lipid bilayer thickness and allowing recruitment
of speciﬁc proteins [2,3]. It has been proposed that lipid microdomains
might provide speciﬁcmembraneproteinswith thenecessarymicroenvi-
ronment for the initiation of signalling pathways [4].2. Toll-like receptors
Toll-like receptors (TLRs) are Type I transmembrane receptors in
charge of recognition of conserved patterns characteristic of bacterial,
viral or fungal invasions, but distinguishable from host molecules, the
so-called Pathogen-Associated Molecular Patterns (PAMPs), and some
endogenous intracellular molecules or extracellular matrix components
released by activated or necrotic cells designed asDanger-AssociatedMo-
lecular Patterns (DAMPs) [5,6]. They are major contributors of the innate
immune system of mammalian organisms and their activation induces
the secretion of pro-inﬂammatorymediators like cytokines, chemokines,
type I interferon (IFN), reactive oxygen species, and other mediators.
The structure of TLRs is characterized by a N-terminal extracellular
domain (ECD) made of leucine-rich repeats (LRRs), short motifs that
fold into a characteristic solenoid structure giving to the ectodomain a
horseshoe-shape, a single transmembrane domain, and a C-terminal in-
tracellular signalling domain that contains a conserved region called the
Toll/IL-1 receptor (TIR) domain, characteristic of the Interleukin-1 re-
ceptor / toll-like receptor superfamily [7–9].
Human TLR family comprises 10 proteins, each of them being spe-
cialized in the recognition of a speciﬁc class of PAMPs. Themost studied
Toll-like receptor, TLR4, recognizes bacterial lipopolysaccharides of the
outer membrane of Gram-negative bacteria, which are responsible for
most dramatic clinical manifestations of bacterial infections in mam-
mals. TLR1, 2 and 6 recognize bacterial and fungal lipoprotein and pep-
tidoglycan; TLR3, TLR7 and 8 recognize respectively viral double
stranded RNA, single stranded DNA and single stranded RNAwhile bac-
terial ﬂagella and unmethylated CpG sequences characteristic of bacte-
rial DNA activate TLR5 and TLR9-dependent signalling cascades,
respectively. The function of human TLR10 is still unclear but seems to
cooperate with the TLR1/2/6 family [8,10].
TLRs can be divided into two subgroups, depending on their cellular
localization: plasmamembrane TLRs include TLR1, TLR2, TLR4 and TLR5,
while other TLRs (TLR3, TLR7, TLR8 and TLR9) localize to and signal from
acidiﬁed compartments of the endolysosomal pathway.
The signalling cascades induced by Toll-like Receptor ligands can be
divided into two main cascades depending on the intracellular adaptor
molecules they recruit. The myeloid differentiation primary response
protein 88 (MyD88) is the main adaptor of the ﬁrst signalling cascade
leading to the activation of Nuclear Factor-κB (NF-κB) and Activated
Protein-1 (AP-1) transcription factors. The second cascade is dependent
on the activation of interferon (IFN)-regulatory factors (IRFs) by TIR
domain-containing adaptor protein inducing IFN-β (TRIF). TLR 1/2/6,
7, 8 and 9 activate exclusively the MyD88-dependent pathway (even
if growing evidence suggests TLR1/2/6 are also capable to activate the
second signalling pathway in some conditions). TLR3 activatesexclusively the TRIF-dependent pathway. TLR4 is generally accepted
as the only Toll-like Receptor activating both signalling pathways [8,10].
Ligands are recognized by the extracellular domains of TLRs at differ-
ent binding sites depending on the receptor. The overall shape of the
signalling TLR-ligand complexes is similar among all TLRs and consists
in am-shaped TLR ECD dimer, in which the N-termini stretch out to op-
posite ends and the C-termini interact in the middle. Dimerization of
TLR monomers is usually induced by ligand recognition (with the ex-
ception of TLR7-8 and 9 existing as an inactive homodimer in non-
activated cells, and which will be activated upon ligand binding after
cleavage in the endosomes) [6,11]. Formation of dimers upon activation
supports the hypothesis that dimerization of the ECDs enforces dimer-
ization of the intracellular signalling TIR domains, hence able to recruit
adaptor molecules and trigger downstream signalling pathways [6,11].
3. Lipid regulation of toll-like receptor activity
3.1. TLR signalling is initiated in lipid microdomains
The existence of membrane lipid microdomains, the so-called lipid
rafts, has been proposed in the nineties by Kai Simons [2]. It is generally
accepted that these short-lived (~100ms)microdomains are cholester-
ol and sphingolipids-enriched regulate the biological activity of proteins
inserted into these lipid domains by inﬂuencing themembrane physico-
chemical properties or through direct binding to proteins. Membrane
lipid partitioning may also lead to the formation of multicomponent
transduction complexes [2] and explain the spatial segregation of cer-
tain signalling pathways emanating from the cell surface [3].
3.1.1. Role of cholesterol
First, it was shown that cholesterol loading of macrophage plasma or
endosomal membranes enhanced the inﬂammatory activity of TLR4 and
3 agonists [12]. More convincingly, depletion of cholesterol or disruption
of lipid rafts by different drugs downregulate the inﬂammatory signal-
ling. The treatment with the cholesterol depleting agent, methyl β-
cyclodextrin (MβCD), causes a decrease of the NF-κB recruitment
into nucleus or a decreased activity of the MyD88-dependent pathway
[13–18]. Furthermore, depletion of cholesterol using, statins or α-
tocopherol derivatives [14,16,19,20] conﬁrmed the importance of
cholesterol-rich domains in TLR initiation. Ethanol, on its turn, modulates
TLR4 activation mechanism by LPS by mimicking the raft-disrupting
agents streptolysin-O or saponin, hence affecting TLR4 partitioning into
rafts after LPS stimulation [16,21,22]. Similarly, the down-regulating ef-
fect of surfactants or oxidized phospholipids on LPS activationwas corre-
lated to a decreased TLR4 translocation into lipid rafts [23,24] while
neither LPS binding nor TLR4 surface expression were reduced.
Finally, macrophages frommice lacking the cholesterol efﬂux pump
ATP-binding cassette subfamily A1 (ABCA1) presented an enhanced
proinﬂammatory response to LPS [25]. It was further demonstrated
that this deﬁciency cause an accumulation of free cholesterol within
lipid rafts and localization of TLRs into rafts explaining the enhanced ac-
tivation of MyD88-dependent signalling pathways by TLR4, 2, 7 and 9
[26]. Modiﬁcation of lipid rafts by treatment with MβCD or nystatin
corrected the abnormal hyper-responsiveness of ABCA1 mutants to
LPS [27]. Similar results were obtained with ABCA1 and ABCG1 double
mutants, presenting a hyper-responsiveness to TLR2, 3 and 4, but not
TLR 7 or 9 agonists which was abolished following treatment with
MβCD or ﬁlipin [28].
3.1.2. Role of sphingomyelin
Recruitment of TLR4/MD2 upon LPS stimulation decreases inmutants
for sphingomyelin synthases SMS1 and SMS2 (responsible for the syn-
thesis of sphingomyelin from ceramide and phosphatidylcholine)
[29–31]. As a consequence, NF-κB activation by LPS in these mutants
was attenuated. Similarly, a partial deﬁciency in the Serine Palmitoyl-
CoA Transferase (SPT) - the key enzyme of the de novo biosynthetic
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TLR4/MD2 on cell surface and decreased NF-κB activation upon LPS stim-
ulation [32]. It should be noted however that SPT deﬁciencywas linked to
an increase of ABCA1 and ABCG1 cell surface expression, increasing the
cholesterol efﬂux, which means that SPT deﬁciency affects both
sphingomyelin synthesis and cholesterol accumulation into plasma
membrane. Moreover, macrophages depleted in sphingomyelin present-
ed attenuated LPS responses [30,33,34].
Finally, one should note that LPS stimulation is followed by a rapid
production of ceramide (resulting from sphingomyelin hydrolysis by
the neutral or acid sphingomyelinase), apparently crucial for LPS activ-
ity since inhibition of the sphingomyelinase blocks signalling events [33,
35,36]. Similarly to TLR4, TLR3 activation up-regulates genes involved in
sphingolipid metabolism and increases sphingomyelin and ceramide
lipid contents [37].
3.1.3. Importance of lipid partitioning for the formation of “activation
clusters”
TLR4 is not detected in lipid raft-enriched fractions isolated from
non-activated cells but is recruited in GM-1 ganglioside (a raft associat-
ed lipid) and CD14 enriched fractions, after LPS stimulation [14]. This
leads to the concept that TLR activation requires the formation of
“supramolecular activation clusters” [38,39] within lipid raft microdo-
mains, offering a platform that brings receptormolecules close together,
allowing their activation and signal transduction [40,41]. Such assem-
blies have been characterized by confocal microscopy or ﬂuorescence
resonance transfer (FRET) between raft constituents, co-receptors and
TLR4 [14,42,42,43], afﬁnity chromatography or peptide-mass ﬁnger-
printing experiments [42,44–46]. The role of these raft-associated
TLR4 activation cluster proteins has been largely discussed [47] and
we will focus here on CD14 and CD36, the two main raft-associated
co-receptors of TLR2 and 4.
Apart from the membrane co-receptors, intracellular co-adaptors for
TLR signalling cascades are also associated to lipid microdomains: MAL
(also known as TIRAP), the co-adaptor of MyD88, and the co-adaptor
for TRIF, TRAM (TRIF-related adaptor molecule). Here again, it was sug-
gested that lipid rafts favour the increased density of lipid-associated
adaptor molecules at the site of TLR4 clustering, as evidenced by the in-
creased TLR4 clustering and signalling following stabilization of lipid
rafts with cholera toxin B (binding GM-1 in lipid raft microdomains)[48].
3.1.3.1. CD14. The Cluster of Differentiation CD14 exists in two forms, one
expressed on the cell surface thanks to a glycosylphosphatidylinositol an-
chor (mCD14) and a soluble form found in the serum (sCD14)[49,50].
Both forms were shown to facilitate LPS recognition by the TLR4/MD-2
complex, but most studies have focused on deciphering the role of the
membrane form in the LPSmachinery. After LPSbinding,mCD14 transfers
LPS to the TLR4/MD-2 complexwhich dimerizes and triggers theMyD88-
dependent pathway and the resulting secretion of pro-inﬂammatory cy-
tokines [38,51]. Once the MyD88-pathway cascade has been triggered,
the TLR4/MD-2/LPS complex is endocyted and activates the TRIF-
dependent production of type I interferons [50,52].
CD14 greatly enhances the detection of LPS by TLR4 but its require-
ment depends also on the LPS phenotype or structure: although CD14 is
required for the detection of smooth LPS (LPS with abundant O-
glycosylation, the more common phenotype of LPS), it is not required
by rough LPS (LPS lacking the O-antigen), MPL (Monophosphoryl
Lipid A) and CRX-527 to activate the MyD88-dependent pathway
[53–56].
Thanks to its GPI anchor, mCD14 is localized in the cholesterol- and
sphingolipid-rich microdomains of the plasma membrane [14,57] and is
essential for the TLR4/MD-2 recruitment into lipid microdomains, a pro-
cess required for efﬁcient dimer formation [58]. This rolewas further con-
ﬁrmed by deciphering the anti-inﬂammatory activity of a cationic lipid
(lipofectamine) on the LPS-induced activation of TLR4: this lipid was
shown to uncouple LPS binding by preventing CD14-TLR4 interactions[59]. The same hypothesis has been formulated for EtOH effect, altering
LPS-related partition of CD14 [16]. It is also believed to be themainmech-
anismofmodulation of immune cascades by oxidized phospholipids [60].
The higher hydrophobicity of rough LPS, MPL and CRX-527, as com-
pared to smooth LPS phenotype, allows a better incorporation of these
ligands into biological membranes and enhanced mobility, and may
therefore explain the non-requirement of mCD14 for activating the
MyD88-dependent pathway [53,54]. Importance of membrane inser-
tion of LPS has been highlighted by several studies using model mem-
branes or giant liposomes, showing a preferential incorporation of LPS
into sphingomyelin and cholesterol-rich domains [61–63] and the abil-
ity of rough LPS, as compared to smooth form, to induce the formation
of lipid microdomains into model membranes [64,65].
However, LPS is unable to activate the TRIF-dependent pathway
in macrophages expressing a truncated inactive variant of CD14,
irrespectively of the LPS phenotype [53]. Since CD14 controls the LPS-
induced endocytosis of the activated TLR4 [66], which is required for
the activation of the TRIF-dependent pathway [52], it is generally accept-
ed that CD14 also controls the internalization of the TLR4/MD-2/LPS com-
plex required to induce the TRIF-dependent pathway [50,66]. This role
has been conﬁrmed by forcing endocytosis of LPS, using latex beads or
cationic liposomes, in the absence of CD14 [66–68].
Clathrin-mediated endocytosis is believed to be the principal
endocytic process [52,69,70] but blocking of this speciﬁc endocytic
pathway using potassium depletion and Dynasore treatment did not in-
hibit completely the internalization of membrane TLR4 upon LPS stim-
ulation. Interestingly, this speciﬁc internalization of membrane TLR4
could be abrogated by depletion of plasma membrane cholesterol
with MβCD [69]. Therefore the role of lipid-raft or caveolin-dependent
mediated endocytosis has emerged [69,71–73].
Apart fromTLR4 signalling, CD14 is also a co-receptor for TLR2, TLR3,
TLR7 and TLR9 [74] and its role in the re-location of TLR2 into lipid rafts,
formation of the TLR2/ligand complex and subsequent activation is well
documented [75–77].
3.1.3.2. CD36. CD36, a member of the class B scavenger receptor family,
acts as a co-receptor for TLR2 [40,78–81] but also for a non-canonical
TLR4/TLR6 heterodimer [82]. CD36 is a membrane protein, found in
lipid microdomains, and which is thought to adopt a hairpin-like struc-
turewith palmitoylated cytoplasmic C and N terminal tails [83,84]. Sim-
ilarly to CD14, it has been suggested that the role of CD36 is to recruit
TLR1/TLR2 heterodimers into lipid rafts upon stimulation [40]. CD36 is
also involved in endocytic uptake of different components including ox-
idized LDL [85] amyloid β peptide [86], and possibly LPS [87], which are
all activators of TLR4 or TLR2-dependent cascades. This suggests that
CD36, similarly to CD14, also regulates internalization of TLRs. Indeed,
TLR2/6 and CD36 co-localized intracellularly following activation with
TLR2 ligands and this localization was prevented by treatment with ei-
ther ﬁlipin or nystatin [40]. Similarly, CD36, TLR4 and TLR6 co-localized
in intracellular compartments following treatmentwith oxLDL and inhi-
bition of dynamin-dependent endocytosis blocked CD36-TLR4-TLR6
signalling induced by oxidized LDL[82].
3.1.3.3. MAL. The adaptor protein MAL (TIRAP) contains a N-terminal
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2 or PIP2) binding
motif, rich in positively-charged lysine residues [88]. Thanks to this an-
chor, MAL is pre-localized into raft lipid microdomains enriched with
PtdIns(4,5)P2 [88]. The recruitment of TLRs into rafts would therefore
favour the interactions with MAL and MyD88 TIR domains, which is a
prerequisite for the induction of the signalling pathway.
3.1.3.4. TRAM. Similarly toMAL, the adaptor protein TRAM is localized in
the plasmamembrane. TRAM contains a N-terminal myristoylation site,
similar to that found in mammalian Src kinases, which is modiﬁed by
the addition of a myristoyl group on a speciﬁc glycine residue.
Myristoylation of TRAM allows its association with the membrane
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chain lipids) but is probably not sufﬁcient to confer stable membrane
binding. It was suggested that several lysine residues close to the
myristoylation site may serve as a polybasic cluster stabilizing mem-
brane binding by electrostatic interactions with phospholipid head
groups of the lipid membrane [89]. Mutation of this myristoylation
site leads to improper localization of TRAM and affects the TLR4-
dependent LPS response [89].
3.2. Lipid-binding sequences within TLRs
TLR dimerization process (required for activation of the TLR1 to
TLR6) is believed to be dependent on both ectodomains (sufﬁcient to
form in vitro dimers after ligand recognition) and transmembrane re-
gions [90]. Isolated transmembrane domains have indeed a strong ten-
dency to oligomerize [91,92] in a homotypic manner. Heterotypic
interactions of transmembrane domains from different TLR showed a
preference for their native dimer partners (i.e. TLR2 transmembrane do-
main heterodimerizewith TLR1, TLR6 or TLR10 TMDs but notwith TLR4
or TLR5) providing evidence of speciﬁc transmembrane domain interac-
tions [91]. Since truncation of the TLR4 ectodomain leads to constitutive
activation after dimerization of the transmembrane and TIR domains, it
was proposed that ectodomain exerts an autoinhibitory effect to pre-
vent spontaneous, ligand-independent dimerization [93].
Upon activation, TLRs migrate to speciﬁc lipid microdomains where
they are activated and able to transmit signals [14,40,94]. It is likely that
the transmembrane region and/or the regions surrounding this se-
quence are involved in the localization of TLRs. It was demonstrated in-
deed that the intracellular localization of TLR9 and TLR7 are governed by
their transmembrane domains [95,96] and that the localization of TLR3
depends on the juxtamembrane domain [96].
Speciﬁc amino acid sequences have been associated with the locali-
zation of proteins within membrane lipid microdomains [97,98]. The
presence of a (or several) Cholesterol Recognition Amino-Acid Consen-
sus (CRAC) sequence and its counterparts, the CARC sequence, in or
near the transmembrane region is considered as indicative of cholester-
ol dependency for efﬁcient protein function [99,100].
3.2.1. CRAC domains
The sequence analysis of human Toll-like receptors reveals the
presence of CRAC (deﬁned as -[LV]-X(1,5)-Y-X(1,5)-[RK]-) and/or CARC
sequences (deﬁned as -[RK]-X(1,5)-Y-X(1,5)-[LV]-) in the cytoplasmic
domain close to the transmembrane region (see Table 1a).Table 1a
The regions surrounding transmembrane domains are represented here for each human TLR. CRAC
and underlined characters in the sequences while CARC corresponding to the CRAC inverted se
green highlighted sequence. Predicted transmembrane region is represented in dark blue bold
Protein
TLR1
TLR2
TLR3
TLR4
TLR5
TLR6
TLR7
TLR8
TLR9
TLR10
Ref. 
Uniprot
Q15399
O60603
O15455
O00206
O60602
Q9Y2C9
Q9NYK1
Q9NR97
Q9NR96
Q9BXR5
Residue
numbers
546–645
554–653
670–769
597–696
605–704
551–650
805–904
793–892
784–883
543–642Although most TLRs (with the exception of TLR5 and TLR9) show
CRAC-like (or CARC) sequences located close to their transmembrane
domain, only TLR2, TLR4, TLR7 and TLR8 possess both CRAC and CARC
sequences. Interestingly, CARC-CRAC-CARC domains into TLR4 are lo-
cated close to the membrane, before the TIR domain. This strongly sug-
gests that this intracellular region of TLR4 binds speciﬁcally cholesterol.
This region corresponds to a sequence previously identiﬁed as a small
hydrophobic segment adjacent to the transmembrane region and the
TIR domain with the consensus sequence FYFHLxLxxGC among mam-
malian species (see Table 1b) which was demonstrated to be required
for both activation and dimerization of TLR4 [101].
It is likely that the increased bilayer thickness of the lipid bilayer in
rafts (due to the high content of saturated acyl chain lipids) favours
the insertion of the ﬁrst CARC motif into lipid bilayer membrane, and
its interaction with cholesterol will lead to structural rearrangements
required for an efﬁcient activation. The presence of CRAC motifs in
TLR4, and the fact that cholesterol is required for activation, suggests
the interaction of this regionwith themembrane (andmore speciﬁcally
the cholesterol) occurs upon activation and is required for efﬁcient di-
merization of the receptors.
Toll-like receptors belongs to the family of Type-I transmembrane
receptorswhich includes receptor tyrosine kinases (RTKs)which are ac-
tivated by ligand-induced dimerization of the receptors [102,103]. The
most studied RTK is the Epidermal Growth Factor (EGF) Receptor
(EGFR) which dimerizes upon recognition of EGF inducing a dramatic
conformational change in both ectodomains and juxtamembrane re-
gions [102,104,105]. Moreover, EGFR has been also found to be inserted
into lipid rafts [104,106] and was reported to be regulated by ganglio-
sides [107–110] (a speciﬁc type of glycosphingolipid located in lipid
rafts), as suggested for TLR2 and TLR4 [111–113] reinforcing the struc-
tural and functional similarities between TLRs and EGFR.
The juxtamembrane cytosolic sequence of EGFR contains several
basic amino acids which are sequestered in the membrane by
interacting with anionic phospholipid head groups in the inactive con-
formation. Upon activation, several residues of two EGFR molecules
(in an active dimeric complex) are pulled out of the plasma membrane
and reassemble as antiparallelα-helices with a kinase activity. Based on
this mechanism, it is likely that cytosolic juxtamembrane sequences of
the TLRs interact with the membrane [6].3.2.2. Sphingolipid domains
Similarly to cholesterol, sphingolipids aremajor components of lipid
microdomains. A signature sequence to be found into the transmem-
brane domains has been deﬁned recently [97]. The sequence analysissequence deﬁned as -[LV]-X(1,5)-Y-X(1,5)-[RK]- [100] is annotated by orange highlighted
quence i.e. -[RK]-X(1,5)-Y-X(1,5)-[LV]- [100], is represented by stars below characters and
and blue highlighted characters.
Table 1b
The regions in TLR4 from different species, surrounding transmembrane domains, are represented here. CRAC sequence deﬁned as -[LV]-X(1,5)-Y-X(1,5)-[RK]- [100] is annotated by orange
highlighted and underlined characters in the sequences while CARC corresponding to the CRAC inverted sequence i.e. -[RK]-X(1,5)-Y-X(1,5)-[LV]- [100], is represented by stars below
characters and green highlighted sequence. Predicted transmembrane region is represented in dark blue bold and blue highlighted characters.
TLR4
Human
Mouse
Cow
Pig
Gorilla
Horse
Dog
Cat
Ref. 
Uniprot
Q15399
O60603
O15455
O00206
O60602
Q9Y2C9
Q9NYK1
Q9NR97
Residue
numbers
624–705
622–703
625–706
625–706
622–703
626–707
625–706
625–706
1864 J.-M. Ruysschaert, C. Lonez / Biochimica et Biophysica Acta 1848 (2015) 1860–1867of human Toll-like receptors reveals the presence of sphingolipid
binding-like sequences in the transmembrane region of TLR3 and
TLR5 (see Table 2). Interestingly, TLR3 which presents a CARC motif in
the juxtamembrane segments close to themembrane (possibly inserted
into membrane bilayer in raft microdomains) also presents two succes-
sive sphingolipid binding-like motifs in its transmembrane segment.
Such coexistence of both speciﬁc sequences has not been reported ear-
lier and strongly suggests that TLR3 interacts with both sphingolipids
and cholesterol. This is in line with the fact that cholesterol accumula-
tion into rafts enhances TLR3 activation (see 3.1.1) and that TLR3 activa-
tion upregulates sphingolipid metabolism (see 3.1.2).
4. Conclusions
Although compelling evidences demonstrate that Toll-like Receptor
signalling depends on the lipid membrane composition, little is known
about themechanismbywhich lipid composition inﬂuence TLR activity.
It has been proposed that lipid microdomains favour clustering of the
TLR activation complexes i.e. TLR and co-receptors like CD14 or CD36.Table 2
The regions surrounding transmembrane domains are represented here for each human TLR. Sphin
[97] and is represented by grey highlighted underlined characters. Predicted transmembrane r
Protein
TLR1
TLR2
TLR3
TLR4
TLR5
TLR6
TLR7
TLR8
TLR9
TLR10
Ref. 
Uniprot
Q15399
O60603
O15455
O00206
O60602
Q9Y2C9
Q9NYK1
Q9NR97
Q9NR96
Q9BXR5
Residue
numbers
546–645
554–653
670–769
597–696
605–704
551–650
805–904
793–892
784–883
543–642Upon ligand recognition, all co-receptors migrate into rafts, bringing
TLRs in close proximity thereby allowing TLR dimerization and activation.
Since CRAC and CARC domains are located into the juxtamembrane
domain of TLR4, it can be suggested that, upon ligand recognition and re-
cruitment into lipid microdomains (with the help of CD14 or another co-
receptor), a structural rearrangement occurs allowing the insertion of the
ﬁrst CARC motif of the juxtamembrane segment of TLR4 region into the
transmembrane stretch (Fig. 1 - upper panel). This rearrangement
would bring the TIR domain closer to the membrane in a way it interacts
withMAL (associated to themembrane thanks to its PIP2 anchor) and ini-
tiates the signalling cascade [114]. After insertion into the lipid bilayer, the
juxtamembrane segment would adopt an alpha-helix secondary struc-
ture (as predicted by secondary prediction programs), extending the
existing transmembrane helix (Fig. 1 - lower panel). This helix would ri-
gidify the juxtamembrane segment, stabilize the TIR domains and favour
the formation of TIR/TIR dimers. This is in agreementwith previous state-
ments that the cytosolic juxtamembrane domain has rotational ﬂexibility
thanks to the presence of several glycine residues able to adopt a wider
range of dihedral angles [115].go-speciﬁc lipid binding region is deﬁned as -[VITL]-X-X-[VITL]-[VITL]-X-X-[VITL]-[YFW]-
egion is represented in dark blue bold and blue highlighted characters.
Fig. 1. Activation of TLR4 before and after stimulation by bacterial lipopolysaccharides (LPS). Inactive TLR4s exist as monomers in lipid membranes before stimulation and are recruited into
lipid microdomains upon stimulation. Upper panel shows the sequence of human TLR4 (622-687) and respective CARC and CRAC domains. Lower panel is a schematic view of the acti-
vation process (shown for theMyD88-dependent pathway only). Due tomembrane thickness increase in the raft domains, part of the juxtamembrane domain (in red) containing a CARC
sequence adopts a helical structure upon insertion into the lipid bilayer. This leads to a shortening of the cytosolic juxtamembrane region and allows TIR domain to get closer to themem-
brane, and to interact with membrane-associated co-receptors like MAL, initiating theMyD88-dependent signalling cascades. It may also suggest that a rotation of the long helix made of
TLR4 transmembrane domain (in blue) and part of the juxtamembrane domain (red) would signiﬁcantly modify the orientation of the cytosolic TIR domains with respect to each other.
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